Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-21-048463

Director sold 325,377 shares at an average $27.36 ($8,901,804)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lettmann Jason Director 2021-12-13 Sale −11,945 $25.29 $302,089 2,127,969 I: show line 1 in the form
Lettmann Jason Director 2021-12-13 Sale −1,627 $25.29 $41,147 290,131 I: show line 2 in the form
Lettmann Jason Director 2021-12-13 Sale −17,169 $26.48 $454,635 2,110,800 I: show line 3 in the form
Lettmann Jason Director 2021-12-13 Sale −2,339 $26.48 $61,937 287,792 I: show line 4 in the form
Lettmann Jason Director 2021-12-13 Sale −286,496 $27.49 $7,875,775 2,101,291 I: show line 5 in the form
Lettmann Jason Director 2021-12-13 Sale −1,296 $27.49 $35,627 286,496 I: show line 6 in the form
Lettmann Jason Director 2021-12-13 Sale −2,196 $28.37 $62,301 2,099,095 I: show line 7 in the form
Lettmann Jason Director 2021-12-13 Sale −299 $28.37 $8,483 286,197 I: show line 8 in the form
Open-market sales · 325,377 sh · avg $27.36 · $8,901,804
Loading xslF345X03/doc4.xml…